FTAWX
Price
$14.71
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
6.27B
FTIWX
Price
$14.75
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
6.27B
Interact to see
Advertisement

FTAWX vs FTIWX

FTAWX vs FTIWX Comparison Chart in %
View a ticker or compare two or three
VS
FTAWX vs. FTIWX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTAWX is a Buy and FTIWX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTAWX (6.27B) and FTIWX (6.27B) have equal amount of cash in the bank . FTIWX pays higher dividends than FTAWX: FTIWX (2.98) vs FTAWX (2.73). FTAWX was incepted earlier than FTIWX: FTAWX (20 years) vs FTIWX (20 years). FTAWX (0.78) is less costly to investors than FTIWX (0.53). FTAWX (31.00) and FTIWX (31.00) have comparable annual turnover. FTAWX (0) and FTIWX (0) have matching initial minimum investment requirements. FTAWX (500) and FTIWX (500) have similar IRA initial investment minimum. FTIWX (8.53) and FTAWX (8.19) have marching annual gain over last year. FTIWX return over 5 years is better than : 14.34 vs. FTAWX (12.81).
FTAWXFTIWXFTAWX / FTIWX
Total Expense Ratio0.760.51149%
Annual Report Gross Expense Ratio0.780.53147%
Fund Existence20 years20 years-
Gain YTD3.7223.84797%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRA500500100%
Net Assets6.27B6.27B100%
Annual Yield % from dividends2.732.9892%
Returns for 1 year8.198.5396%
Returns for 3 years22.8723.9096%
Returns for 5 years12.8114.3489%
Returns for 10 years34.9438.6091%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBVA27.950.35
+1.27%
Banco Bilbao Vizcaya Argentaria SA
UAN128.991.01
+0.79%
CVR Partners LP
CEPO10.66-0.01
-0.09%
Cantor Equity Partners I Inc
BLLN138.60-0.99
-0.71%
Billiontoone Inc
ACTU1.11-0.06
-5.13%
Actuate Therapeutics Inc